148 related articles for article (PubMed ID: 37159513)
1. CRISPR Correction of the GBA Mutation in Human-Induced Pluripotent Stem Cells Restores Normal Function to Gaucher Macrophages and Increases Their Susceptibility to Mycobacterium tuberculosis.
Ramalingam S; Kumar A; Krug S; Mohan H; Rao DN; Bishai WR; Chandrasegaran S
J Infect Dis; 2023 Sep; 228(6):777-782. PubMed ID: 37159513
[TBL] [Abstract][Full Text] [Related]
2. Potential Binding Sites of Pharmacological Chaperone NCGC00241607 on Mutant β-Glucocerebrosidase and Its Efficacy on Patient-Derived Cell Cultures in Gaucher and Parkinson's Disease.
Kopytova AE; Rychkov GN; Cheblokov AA; Grigor'eva EV; Nikolaev MA; Yarkova ES; Sorogina DA; Ibatullin FM; Baydakova GV; Izyumchenko AD; Bogdanova DA; Boitsov VM; Rybakov AV; Miliukhina IV; Bezrukikh VA; Salogub GN; Zakharova EY; Pchelina SN; Emelyanov AK
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240451
[TBL] [Abstract][Full Text] [Related]
3. Generation of two iPSC lines derived from two unrelated patients with Gaucher disease.
Nagel M; Reichbauer J; Böhringer J; Schelling Y; Krägeloh-Mann I; Schüle R; Ulmer U
Stem Cell Res; 2019 Mar; 35():101336. PubMed ID: 30606667
[TBL] [Abstract][Full Text] [Related]
4. A common and two novel GBA mutations in Thai patients with Gaucher disease.
Tammachote R; Tongkobpetch S; Srichomthong C; Phipatthanananti K; Pungkanon S; Wattanasirichaigoon D; Suphapeetiporn K; Shotelersuk V
J Hum Genet; 2013 Sep; 58(9):594-9. PubMed ID: 23719189
[TBL] [Abstract][Full Text] [Related]
5. Establishment of MUi030-A: A human induced pluripotent stem cell line carrying homozygous L444P mutation in the GBA1 gene to study type-3 Gaucher disease.
Kangboonruang K; Pornsukjantra T; Tong-Ngam P; Chokpanuwat T; Tim-Aroon T; Wattanasirichaigoon D; Anurathapan U; Hongeng S; Asavapanumas N; Bhukhai K; Tubsuwan A
Stem Cell Res; 2023 Dec; 73():103229. PubMed ID: 37890332
[TBL] [Abstract][Full Text] [Related]
6. Ambroxol increases glucocerebrosidase (GCase) activity and restores GCase translocation in primary patient-derived macrophages in Gaucher disease and Parkinsonism.
Kopytova AE; Rychkov GN; Nikolaev MA; Baydakova GV; Cheblokov AA; Senkevich KA; Bogdanova DA; Bolshakova OI; Miliukhina IV; Bezrukikh VA; Salogub GN; Sarantseva SV; Usenko TC; Zakharova EY; Emelyanov AK; Pchelina SN
Parkinsonism Relat Disord; 2021 Mar; 84():112-121. PubMed ID: 33609962
[TBL] [Abstract][Full Text] [Related]
7. Generation of patient-derived pluripotent stem cell-lines and CRISPR modified isogenic controls with mutations in the Parkinson's associated GBA gene.
X-Q Chen C; Deneault E; Abdian N; You Z; Sirois J; Nicouleau M; Shlaifer I; Villegas L; Boivin MN; Gaborieau L; Karamchandani J; Beitel LK; Fon EA; Durcan TM
Stem Cell Res; 2022 Oct; 64():102919. PubMed ID: 36130446
[TBL] [Abstract][Full Text] [Related]
8. Glucocerebrosidase mutations and the pathogenesis of Parkinson disease.
Beavan MS; Schapira AH
Ann Med; 2013 Dec; 45(8):511-21. PubMed ID: 24219755
[TBL] [Abstract][Full Text] [Related]
9. Genotype/phenotype relationship in Gaucher disease patients. Novel mutation in glucocerebrosidase gene.
Lepe-Balsalobre E; Santotoribio JD; Nuñez-Vazquez R; García-Morillo S; Jiménez-Arriscado P; Hernández-Arévalo P; Delarosa-Rodríguez R; Guerrero JM; Macher HC
Clin Chem Lab Med; 2020 Jun; 58(12):2017-2024. PubMed ID: 32589593
[TBL] [Abstract][Full Text] [Related]
10. Involvement of Gaucher Disease Mutations in Parkinson Disease.
Vilageliu L; Grinberg D
Curr Protein Pept Sci; 2017; 18(7):758-764. PubMed ID: 26965692
[TBL] [Abstract][Full Text] [Related]
11. Viral delivery of a microRNA to Gba to the mouse central nervous system models neuronopathic Gaucher disease.
Jackson KL; Viel C; Clarke J; Bu J; Chan M; Wang B; Shihabuddin LS; Sardi SP
Neurobiol Dis; 2019 Oct; 130():104513. PubMed ID: 31233883
[TBL] [Abstract][Full Text] [Related]
12. Glucocerebrosidase and Parkinson disease: Recent advances.
Schapira AH
Mol Cell Neurosci; 2015 May; 66(Pt A):37-42. PubMed ID: 25802027
[TBL] [Abstract][Full Text] [Related]
13. The heat shock protein amplifier arimoclomol improves refolding, maturation and lysosomal activity of glucocerebrosidase.
Fog CK; Zago P; Malini E; Solanko LM; Peruzzo P; Bornaes C; Magnoni R; Mehmedbasic A; Petersen NHT; Bembi B; Aerts JFMG; Dardis A; Kirkegaard T
EBioMedicine; 2018 Dec; 38():142-153. PubMed ID: 30497978
[TBL] [Abstract][Full Text] [Related]
14. Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation.
Fishbein I; Kuo YM; Giasson BI; Nussbaum RL
Brain; 2014 Dec; 137(Pt 12):3235-47. PubMed ID: 25351739
[TBL] [Abstract][Full Text] [Related]
15. The contribution of mutant GBA to the development of Parkinson disease in Drosophila.
Maor G; Cabasso O; Krivoruk O; Rodriguez J; Steller H; Segal D; Horowitz M
Hum Mol Genet; 2016 Jul; 25(13):2712-2727. PubMed ID: 27162249
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the β-glucocerebrosidase gene in Turkish Gaucher disease patients: mutation profile and description of a novel mutant allele.
Karaca E; Kalkan S; Onay H; Aykut A; Coker M; Ozkinay F
J Pediatr Endocrinol Metab; 2012; 25(9-10):957-62. PubMed ID: 23426826
[TBL] [Abstract][Full Text] [Related]
17. Neurological effects of glucocerebrosidase gene mutations.
Mullin S; Hughes D; Mehta A; Schapira AHV
Eur J Neurol; 2019 Mar; 26(3):388-e29. PubMed ID: 30315684
[TBL] [Abstract][Full Text] [Related]
18. TALEN-mediated generation and genetic correction of disease-specific human induced pluripotent stem cells.
Ramalingam S; Annaluru N; Kandavelou K; Chandrasegaran S
Curr Gene Ther; 2014; 14(6):461-72. PubMed ID: 25245091
[TBL] [Abstract][Full Text] [Related]
19. Glucocerebrosidase enzyme activity in GBA mutation Parkinson's disease.
Ortega RA; Torres PA; Swan M; Nichols W; Boschung S; Raymond D; Barrett MJ; Johannes BA; Severt L; Shanker V; Hunt AL; Bressman S; Pastores GM; Saunders-Pullman R
J Clin Neurosci; 2016 Jun; 28():185-6. PubMed ID: 26857292
[TBL] [Abstract][Full Text] [Related]
20. Gaucher iPSC-derived macrophages produce elevated levels of inflammatory mediators and serve as a new platform for therapeutic development.
Panicker LM; Miller D; Awad O; Bose V; Lun Y; Park TS; Zambidis ET; Sgambato JA; Feldman RA
Stem Cells; 2014 Sep; 32(9):2338-49. PubMed ID: 24801745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
